Literature DB >> 21784728

Association of variants in MMEL1 and CTLA4 with rheumatoid arthritis in the Han Chinese population.

Patrick Danoy1, Meng Wei, Hadler Johanna, Lei Jiang, Dongyi He, Linyun Sun, Xiaofeng Zeng, Peter M Visscher, Matthew A Brown, Huji Xu.   

Abstract

BACKGROUND: The genome-wide association study era has made great progress in identifying susceptibility genes and genetic loci for rheumatoid arthritis (RA) in populations of White European ancestry. However, few studies have tried to dissect disease aetiopathogenesis in other ethnic populations.
OBJECTIVE: To investigate these associations in the Han Chinese population.
METHODS: Haplotypes from the HapMap database Chinese population were used to select tag-single-nucleotide polymorphisms (SNPs) (r(2)=0.8) across 19 distinct RA genomic regions. A two phase case-control association study was performed, with 169 SNPs genotyped in phase I (n=571 cases, n=880 controls), and 64 SNPs achieving p<0.2 in the first phase being genotyped in phase II (n=464 cases, n=822 controls). Association statistics were calculated using permutation tests both unadjusted and adjusted for the number of markers studied.
RESULTS: Robust association was detected for MMEL1 and CTLA4, and modest association was identified for another six loci: PADI4, STAT4, PRDM1, CDK6, TRAF1-C5 and KIF5A-PIP4K2C. All three markers genotyped in MMEL1 demonstrated association, with peak signal for rs3890745 (p=2.6 × 10(-5) unadjusted, p=0.003 adjusted, OR=0.79). For CTLA4, significance was detected for three of five variants showing association, with peak association for marker rs12992492 (p=4.3 × 10(-5) unadjusted, p=0.0021 adjusted, OR=0.77). Lack of association of common variants in PTPN22 with RA in Han Chinese was confirmed.
CONCLUSION: This study identifies MMEL1 and CTLA4 as RA susceptibility genes, provides suggestive evidence of association for a further six loci in the Han Chinese population and confirms lack of PTPN22 association in Asian populations. It also confirms the value of multiethnic population studies to help dissect disease aetiopathogenesis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21784728     DOI: 10.1136/ard.2010.144576

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  6 in total

Review 1.  GWAS in autoimmune thyroid disease: redefining our understanding of pathogenesis.

Authors:  Matthew J Simmonds
Journal:  Nat Rev Endocrinol       Date:  2013-03-26       Impact factor: 43.330

2.  Association of polymorphisms in interleukin (IL)-12A and -B genes with rheumatoid arthritis in a Chinese population.

Authors:  E-Y Wang; Q Yang; Z-G Liao
Journal:  Clin Exp Immunol       Date:  2015-04       Impact factor: 4.330

3.  Rheumatoid arthritis and primary biliary cirrhosis: cause, consequence, or coincidence?

Authors:  Daniel S Smyk; Dimitrios P Bogdanos; Maria G Mytilinaiou; Andrew K Burroughs; Eirini I Rigopoulou
Journal:  Arthritis       Date:  2012-10-24

4.  RADB: a database of rheumatoid arthritis-related polymorphisms.

Authors:  Ruijie Zhang; Meiwei Luan; Zhenwei Shang; Lian Duan; Guoping Tang; Miao Shi; Wenhua Lv; Hongjie Zhu; Jin Li; Hongchao Lv; Mingming Zhang; Guiyou Liu; He Chen; Yongshuai Jiang
Journal:  Database (Oxford)       Date:  2014-09-15       Impact factor: 3.451

5.  Replication of GWAS Coding SNPs Implicates MMEL1 as a Potential Susceptibility Locus among Saudi Arabian Celiac Disease Patients.

Authors:  Omar I Saadah; Noor Ahmad Shaik; Babajan Banaganapalli; Mohammed A Salama; Sameer E Al-Harthi; Jun Wang; Harbi A Shawoosh; Sharifa A Alghamdi; Yagoub Y Bin-Taleb; Bakr H Alhussaini; Ramu Elango; Jumana Y Al-Aama
Journal:  Dis Markers       Date:  2015-12-30       Impact factor: 3.434

6.  Association between CTLA-4 gene polymorphism and risk of rheumatoid arthritis: a meta-analysis.

Authors:  Chuankun Zhou; Shutao Gao; Xi Yuan; Zixing Shu; Song Li; Xuying Sun; Jun Xiao; Hui Liu
Journal:  Aging (Albany NY)       Date:  2021-08-02       Impact factor: 5.682

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.